Abstract
Transient receptor potential cation channel subfamily M member 7 (TRPM7) is an ion channel/protein kinase belonging to the TRP melastatin and eEF2 kinase families. Under physiological conditions, most native TRPM7 channels are inhibited by cytoplasmic Mg2+, protons, and polyamines. Currents through these channels (ITRPM7) are robustly potentiated when the cell interior is exchanged with low Mg2+-containing buffers. ITRPM7 is also potentiated by phosphatidyl inositol bisphosphate (PI(4,5)P2) and suppressed by its hydrolysis. Here we characterized internal Mg2+- and pH-mediated inhibition of TRPM7 channels in HEK293 cells overexpressing WT voltage-sensing phospholipid phosphatase (VSP) or its catalytically inactive variant VSP-C363S. VSP-mediated depletion of membrane phosphoinositides significantly increased channel sensitivity to Mg2+ and pH. Proton concentrations that were too low to inhibit ITRPM7 when the VSP-C363S variant was expressed (pH 8.2) became inhibitory in WT VSP–expressing cells. At pH 6.5, protons inhibited ITRPM7 both in WT and VSP C363S–expressing cells but with a faster time course in the WT VSP–expressing cells. Inhibition by 150 μm Mg2+ was also significantly faster in the WT VSP–expressing cells. Cellular PI(4,5)P2 depletion increased the sensitivity of TRPM7 channels to the inhibitor 2-aminoethyl diphenyl borinate, which acidifies the cytosol. Single substitutions at Ser-1107 of TRPM7, reducing its sensitivity to Mg2+, also decreased its inhibition by spermine and acidic pH. Furthermore, these channel variants were markedly less sensitive to VSP-mediated PI(4,5)P2 depletion than the WT. We conclude that the internal Mg2+-, polyamine-, and pH-mediated inhibition of TRPM7 channels is not direct but, rather, reflects electrostatic screening and resultant disruption of PI(4,5)P2–channel interactions.
Keywords: channel activation, phosphoinositide, polyamine, magnesium, transfection, transient receptor potential channels (TRP channels), mutant, gain-of-function mutation, TRPM, voltage-sensitive phosphatase
Introduction
TRPM7 (channel kinase 1 (ChaK1)) and the closely related TRPM6 (channel kinase 2 (ChaK2)) are unusual membrane proteins containing a transient receptor potential (TRP)3 channel and a serine/threonine kinase domain (1–4). TRPM7 is highly expressed in cells involved in immunity (such as lymphocytes, macrophages, microglia, and mast cells), various cancer cell lines (5–11), as well as cardiac and vascular smooth muscle and the kidney (12–15). The commonly used cell lines HEK293, COS7, CHO-K1, HeLa, and others express substantial outwardly rectifying cation currents mediated by TRPM7 (16–19). A salient feature of TRPM7 channels is their sensitivity to cytoplasmic Mg2+, protons, and polyamines (6, 7). Mg2+ inhibits Jurkat T cell TRPM7 channels with a biphasic concentration dependence involving ∼10 μm and ∼165 μm IC50 inhibitor sites (20). Biphasic Mg2+ dependence has also been described for heterologously expressed murine TRPM7 channels (21). By contrast, intracellular protons inhibit with a single pKa of 6.3 (20). The mechanism of inhibition by these cations has remained a mystery since it was first described. We showed that Mg2+ is not unique in its inhibitory actions and that other divalent (Mn2+, Ca2+, Ba2+) and trivalent (La3+) metal cations inhibit in a similar fashion (22). The polyamines spermine (+4 charge), spermidine (+3), and putrescine (+2) inhibit native TRPM7 channels with potencies matching their overall positive electrostatic charge. Neomycin and poly-lysine, large polyvalent cations known to sequester anionic phospholipids (23), are also effective inhibitors (7). An alternative view proposes that inhibition of channel activity by Mg2+ reflects binding of Mg-ATP and other Mg-nucleotides to the C-terminal kinase domain, which somehow communicates this event to the pore and closes it (24–27). In support of this mechanism, channel Mg2+ sensitivity is reduced in cells from TRPM7 kinase–inactivated transgenic mice compared with the WT (28).
In whole-cell recordings, internal protons and polyvalent cations reduce TRPM7 current amplitude without altering its voltage dependence (6). By contrast, Mg2+ and polyamines applied on the extracellular side produce a rapid voltage-dependent channel pore block (6, 29, 30). Tonic blockade of inward monovalent current by external Ca2+/Mg2+ gives rise to the characteristic steep outward rectification of ITRPM7 (22).
At the single-channel level, inhibition by Mg2+ is a combination of two effects: a gradual reduction of the number of conducting channels and an abrupt ∼20% drop in the unitary monovalent (39 pS) conductance, seen only with higher Mg2+ concentrations (>100 μm) (31). In some patches, TRPM7 channels were not sensitive to low micromolar Mg2+, whereas in others, Mg2+ sensitivity increased upon repeated Mg2+ additions, a phenomenon we termed use dependence (i.e. sensitization). We hypothesized that, in whole-cell recordings, current rundown in the presence of Mg2+ reflects a gradual increase in the channels' sensitivity to Mg2+, akin to the sensitization observed in cell-free patches (31). Current rundown follows the depletion of phosphoinositides in the channel vicinity when ATP is absent (e.g. (6, 32)) and can be prevented simply by reducing the Mg2+ concentration to nanomolar levels without supplying exogenous phospholipids (7). Presumably, the role of ATP here is to enable replenishment of PIPs by endogenous phospholipid kinases (33–36). Rundown is commonly seen when micromolar or higher concentrations of Mg2+ or spermine are present in the internal solutions (7).
Depletion of membrane PI(4,5)P2 (hereafter referred to as PIP2) by phospholipase C β and γ inhibits whereas exogenous PIP2 activates TRPM7 channels (7, 32, 34). Expression of a heterologous protein that dephosphorylates plasma membrane PIPs at the 5′ position, the voltage-sensing phosphatase (VSP) (37, 38), suppressed TRPM7 channel activity (39).
We proposed previously that inhibition by high internal Mg2+, polyamines, and acidic pH represents screening (electrostatic shielding) of negative charges on the phospholipid co-factors of these channels without directly demonstrating this (7). Here we investigated whether depletion of PIP2 by expressing VSP is sufficient to mimic inhibition of TRPM7 channels by these cytosolic cations. We find that PIP2 depletion significantly increases the sensitivity of TRPM7 channels to Mg2+ and protons, in agreement with our hypothesis that these ions act by screening the negative charges of PIP2 phosphates. Sensitivity to propionate or 2-aminoethyl diphenyl borinate (2-APB), an inhibitor that acidifies the cytosol (40), is also significantly augmented by PIP2 depletion. TRPM7 Ser-1107 (41) mutants, which have been reported to be Mg2+-insensitive, were also less sensitive to spermine and pH. Importantly, the same mutants (S1107E and S1107R) were significantly less sensitive to PIP2 depletion than WT channels. These observations revealed that inhibition by internal Mg2+ and other cations shares a common mechanism and depends on cellular PIP2 levels.
Results
Effect of VSP expression on Mg2+ sensitivity of native TRPM7 channels
HEK293 cells express significant magnesium-inhibited cation currents representing TRPM7 channel activity (20, 30). We took advantage of the ease of transfecting this cell type to investigate the effects of VSP-mediated PIP2 depletion on endogenous TRPM7 channel activity. We compared TRPM7 channel currents in HEK cells transfected with WT (active) and C363S mutant (inactive) CiVSP (38, 42). Fig. 1 shows current–voltage (I–V) relations obtained with 10 μm and 150 μm free [Mg2+]i in cells expressing WT and C363S VSP. I–V shapes were unchanged by VSP expression or by Mg2+ (Fig. 1, A, B, D, and E). In GFP+ cells transfected with C363S, there was no noticeable current reduction over time with 10 μm Mg2+ (Fig. 1A), whereas in WT VSP–expressing cells, the current declined during the experiment (Fig. 1, B and C).
150 μm [Mg2+], by contrast, was sufficient to inhibit TRPM7 channels in all tested WT cells and the majority of C363S-expressing cells (Fig. 1, D–F). Time courses for 10 μm and 150 μm internal Mg2+ are shown in Fig. 1, C and F; in the absence of PIP2 depletion (i.e. C363S expression), currents developed slowly after the whole-cell configuration was established and usually reached a maximum 2–6 min later (addressed in more detail in Fig. 2). Current suppression by Mg2+ could be well-fitted with single exponential decay functions (Fig. 1, C and F).
We further analyzed the primary data presented in Fig. 1 by dividing the current measured at 6 min by the maximum attained amplitude for each cell. This ratio gives a simple measure of Mg2+-induced current decay that follows the initial rise phase (18). It is a single-cell, “steady state” alternative to population measurements of Imax commonly used in studies of TRPM7 channel Mg2+ dependence (e.g. (20, 24). In Fig. 2, A and B, I6min/Imax ratios for individual cells at two Mg2+ concentrations are presented, grouped according to the VSP variant expressed. These data, summarized in Fig. 2C, demonstrate that when PIP2 was not depleted (C363S VSP transfection), TRPM7 currents did not decay noticeably at 10 μm Mg2+ during our recordings. By contrast, expression of WT VSP and consequent PIP2 depletion resulted in a drastic sensitization of the channels to Mg2+; ∼50.8% to 61.1% of the maximum current declined after 6 min of dialysis. WT VSP–expressing cells that showed less decay most likely represent a subpopulation where the enzyme activity was low, leaving PIP2 levels high (Fig. 2A). Alternatively, these cells may express high levels of endogenous PI 5-kinase enzymes thought to be responsible for PIP2 replenishment (36).
The higher 150 μm Mg2+ concentration was sufficient to decrease currents in the majority of C363S-expressing cells (Fig. 2B). The decrease was more pronounced in WT VSP–expressing cells; on average, 78.9% of the current compared with 34.4% for C363S (Fig. 2, B and C). In a minority of C363S-expressing cells, 150 μm was ineffective, producing no current reduction, whereas such an Mg2+-insensitive population was absent among WT VSP–expressing cells (Fig. 2B). In WT VSP–expressing cells, percent remaining current was indeed higher at 10 μm (Fig. 2D, black) than 150 μm Mg2+ (Fig. 2D, red), suggesting that current decay is faster at higher Mg2+ concentrations.
WT VSP–expressing cells showed highly variable current amplitudes, even in the same batch of cells (see scatterplots in Fig. 2A). This variability may be due to the heterogeneity of HEK cell resting membrane potentials and consequent differences in basal lipid phosphatase activity during culturing (see “Discussion”). Because culturing, transfection, and voltage protocols were identical for all cells, it is unlikely that the degree of VSP activation during the recording was the cause of the observed disparity (36). An alternative explanation is that not all GFP+ cells express equal amounts of VSP because, in the transfected cell, GFP and VSP are synthesized from one transcript as separate proteins (see “Experimental Procedures”).
We next compared the decay phases of the current in WT VSP–expressing cells for both Mg2+ concentration (Fig. 1, C and F). The decay time constant (τ) was significantly lower with increased internal Mg2+ concentration (Fig. 2, E and F). Thus, at increased Mg2+ concentrations, the apparent onset of inhibition was accelerated in PIP2-depleted cells.
Exponential decay time constants for WT (n = 12 cells) and C363S-expressing cells (n = 8 cells) were compared for 150 μm Mg2+ but were not statistically significantly different (mean ± S.E. for WT and C363S were 85.13 ± 18.40 and 48.90 ± 5.81, respectively; Student's t test, p = 0.315).
We next focused our attention on the rising phase of TRPM7 current and its dependence on PIP2 levels. To this end, the times required to reach maximum were examined in WT- and C363S-expressing cells as a measure of the rate of current development after break-in using two Mg2+ concentrations. Unexpectedly, we found that rise times were shorter in PIP2-depleted cells than in control cells. Thus, at 10 μm Mg2+, the mean rise time was ∼6 min in control cells (C363S) but only ∼2 min in PIP2-depleted (WT) cells, a 3-fold change (Fig. 2, G and I). At 150 μm [Mg2+], the times to reach maximum were decreased in both C363S- and WT-expressing cells (Fig. 2H). This suggested that the effect of increasing [Mg2+] on the time to reach maximum current can also be mimicked by PIP2 depletion. The time to reach maximum current in each cell is set by a competition between the rising and the decay phase; i.e. when inhibition is accelerated, it will overwhelm the rising phase and manifest as an earlier drop in current magnitude.
To determine whether the shorter times to maximum in PIP2-depleted cells reflected a faster current activation, we fitted the rise times with monoexponential functions for C363S- and WT VSP–expressing cells. We limited our analysis to WT VSP–expressing cells that showed decay and C363S-expressing cells that showed no decay in current. At 10 μm Mg2+, the time constants were 94.01 ± 19.03 for C363S and 72.9 ± 12.36 for WT VSP (mean ± S.E.). Thus, there was a tendency for PIP2 depletion to accelerate the initial rise of current, which was not statistically significant (Student's t test). For 150 μm, such a comparison was not performed because the current did not increase in most WT VSP–expressing cells (Fig. 1). We conclude that the reduction in time to maximum (Fig. 2, G–I) is primarily due to an effect on the decay phase rather than the initial potentiation of the current.
Effect of PIP2 depletion on pH regulation and 2-APB sensitivity of TRPM7 channels
Next we investigated whether the dependence of native TRPM7 channel activity on cytosolic pH is also governed by cellular PIP2 levels, as hypothesized previously (7, 20). We tested two internal solutions that were fixed at acidic (6.5) and basic (8.2) pH values. pH 8.2 (corresponding to [H+] ≈ 10 nm) did not suppress TRPM7 channels in control C363S cells but became inhibitory in WT VSP–transfected cells (Fig. 3) (20). In C363S-expressing cells, the TRPM7 channel current decayed slowly at pH 6.5 ([H+] ∼ 1 μm) (Fig. 3A). In WT VSP–expressing PIP2-depleted cells, the current reduction at pH 6.5 was markedly faster (Fig. 3, A and B). The internal free Mg2+ concentration in these experiments was held constant at 100 nm, a low concentration that prevents channel rundown (31, 40). 2 min or 6 min after reaching the maximum, remaining TRPM7 currents were significantly lower in WT VSP compared with C363S-expressing cells (Fig. 3, B and C).
A two-way analysis of variance performed using TRPM7 current amplitudes remaining 2 min after reaching maximum (Fig. 3B) showed a significant interaction between PIP2 depletion and the inhibitory effect of protons (p < 0.0001). Thus, decreasing the cytoplasmic pH had a higher inhibitory effect on TRPM7 channels that were PIP2-depleted (i.e. WT VSP–expressing cells) compared with nondepleted channels (C363S VSP).
To examine the effect of cytoplasmic acidification on TRPM7 channels in the absence of rundown, we employed the perforated patch recording configuration, which does not perturb the cellular Mg2+. In the perforated patch, TRPM7 channels do not run down, presumably because PIP2 is not depleted. We transfected HEK cells with mTRPM7 and studied its dependence on acidification induced by application of sodium propionate, a salt of a weak acid (7). As shown in Fig. 4A, repeated applications of 20 mm propionate resulted in reversible inhibition of TRPM7 currents. The extent of inhibition did not change significantly over time. We then performed the same experiment in whole-cell mode with 3 μm Mg2+ in the pipette (Fig. 4B). In this case, repeated application of 20 mm propionate resulted in progressively stronger inhibition of the current. 3 μm Mg2+ is sufficient to support TRPM7 current rundown, likely involving the high-affinity Mg2+ inhibitor site (20). In whole-cell recordings with a lower (400 nm) Mg2+ concentration, which does not support rundown, repeated applications of propionate inhibited the current to a similar extent (Fig. 4C). This behavior was similar to that seen in the perforated patch mode (Fig. 4A). Therefore, PIP2 depletion in whole-cell recordings results in stronger inhibition by cytoplasmic protons, which is not seen in perforated-patch recordings when PIP2 is not depleted. This is in agreement with the experiments described in Fig. 3, where PIP2 was depleted by VSP expression. Thus, the pH and Mg2+ sensitivities of TRPM7 channels are interdependent. The role of low micromolar Mg2+ in channel rundown only becomes apparent when PIP2 is depleted during whole-cell dialysis because the channels do not run down in the perforated patch even though the cytoplasmic Mg2+ is in the millimolar range.
2-APB, a compound widely used in ion channel research, inhibits TRPM7 channels indirectly by acidifying the cytosol (40). Therefore, we compared inhibition by 100 μm 2-APB in HEK cells to determine whether it depended on PIP2. In C363S CiVSP–expressing cells, this concentration of 2-APB had only a small effect on the current at internal free [Mg2+] of 400 nm (Fig. 5, A and C). By contrast, in WT CiVSP–expressing cells, 2-APB robustly inhibited the current in 1–2 min (Fig. 5, B and D). Washout of the drug fully reversed inhibition in C363S but only partially in some WT VSP–expressing cells (Fig. 5, B and D). Current decay in WT VSP–expressing cells was substantially slower when 0.05% DMSO was applied without 2-APB (Fig. 5E). On average, 2-APB inhibited 81.8% of the current for WT versus 8% for C363S cells, quantified ∼3.0 min after application (Fig. 5E). 2-APB inhibition was also increased in cells expressing WT DrVSP, which activates at more depolarized potentials than Ciona enzyme (Fig. 5F). As expected, 2-APB inhibition was voltage-independent (Fig. 5, A and B) (40). These results suggest that the potency of 2-APB is increased because TRPM7 channels in PIP2-depleted cells are more sensitive to inhibition by protons than in nondepleted controls.
The effect of VSP on TRPM7 channels can occur without depolarization
TRPM7 and TRPM6 channel activity is commonly recorded by applying voltage ramps reaching +80 to +100 mV (see Fig. 1) (6). To rule out partial activation of VSP by depolarizations during voltage ramps that briefly reach +85 mV, as suggested for TRPM6 (39), we took advantage of the change in TRPM7 I–V relation when external divalent cations are removed; under such conditions, TRPM7 becomes semilinear and allows the measurement of large currents well below 0 mV, where CiVSP should be mostly inactive. We compared TRPM7 current decay using voltage ramps from −100 to +20 mV in WT and C363S VSP–expressing cells (Fig. 6, A–D). As seen with ramps reaching +85 mV (Fig. 1), native TRPM7 currents declined in minutes in WT but not C363S VSP–expressing cells (Fig. 6E). This observation is in agreement with reduced current magnitudes at break-in (I0) measured in WT VSP–expressing cells (Fig. S1, A and C) and suggests that VSP is active and can deplete PIPs in HEK cells even without depolarizing voltages.
HEK cells have reported membrane potentials of −40 to −50 mV (43). We therefore sought to evaluate VSP effects under depolarizing, high K+ conditions. Elevating the external [K+] from 5.3 mm of the normal RPMI medium to 25.3 mm is expected to shift the K+ equilibrium potential by +41 mV. Break-in current amplitudes in WT VSP-transfected cells grown in low (15 cells) and high [K+] (10 cells) that exhibited current decay were not significantly different (Student's test, p = 0.05) (Fig. 6F). We observed no differences in VSP-induced current decay in cells grown in 5.3 or 25.3 mm [K+] either (data not shown). The mean Imax was higher for C363S than WT VSP–expressing cells at both K+ concentrations (p < 0.05) (Fig. 6F). These results suggest that either the HEK cell membrane is depolarized already or there is significant lipid phosphatase activity that does not require depolarization. To address this question, we measured the resting membrane potentials of HEK cells in perforated patch recordings, obtaining mean ± S.D. values of −59.7 ± 2.1 mV, −47.5 ± 2.7 mV, −34.8 ± 1.7 mV, −32.4 ± 1.2 mV, −33.9 ± 2.4 mV, and −27.8 ± 0.9 mV (6 cells), similar to published values. Cells with more hyperpolarized membrane potentials exhibited a prominent outward K+ current upon switching to voltage clamp (data not shown).
Zebrafish VSP (DrVSP) is activated at more depolarized membrane potentials than its Ciona ortholog (44). The half-activation voltage of DrVSP is 94.27 ± 6.83 mV compared with 62.9 ± 4.5 mV for CiVSP (45). Expression of WT DrVSP in HEK cells resulted in a decay of native TRPM7 currents using −100 to +20 mV ramps, albeit at a slower rate (Fig. 6G). By contrast, currents did not decay in cells transfected with the inactive DrVSP C302S mutant (Fig. 6G). Collectively, the data presented in Figs. 6 and Fig. S1 (see also Fig. 5) strongly suggest that at least some VSP-induced PIP2 depletion occurs at negative membrane potentials and does not require depolarization.
Point mutations reducing channel sensitivity to Mg2+ also reduce its sensitivity to spermine and pH
Ser-1107 lies immediately outside of the TRP domain (Fig. 7A) of TRPM7 and has been reported to make Mg2+-insensitive ion channels when substituted with glutamate (41). This serine residue is conserved in the human TRPM7 and in the closely related TRPM6 channel. In view of our proposal that polyamines and pH exert inhibition of TRPM7 channels through the same mechanism as Mg2+ (see “Introduction”), we tested various S1107 mutants for their sensitivity to spermine and pH. We first tested the S1107E mutant, originally described as Mg2+-insensitive (41). Indeed, both spermine and protons were less inhibitory for this mutant (Fig. 7, B–E). We further examined the 1107 position by mutagenizing this serine to positively charged lysine and arginine instead of negatively charged glutamate. Both lysine and arginine mutants also exhibited diminished Mg2+ sensitivity accompanied by reduced spermine and pH sensitivity (Fig. 7, B–E). As a next step, we mutagenized the same serine to alanine, glutamine, threonine, and aspartate. Surprisingly, no correlation between the charge of this residue and channel sensitivity to Mg2+ was observed. However, we found that the size (surface area) of the substituting residue determined the channel phenotype. For example, changing Ser-1107 to glutamic acid or glutamine, having a similar size but differing in charge, both resulted in Mg2+-insensitive channels (summarized in Fig. 7E).
WT, S1107A, and S1107T TRPM7 magnitudes increased after break-in with 0 Mg2+ internal solution, whereas S1107E, S1107R, S1107K, and S1107Q currents were at their maximum magnitude at break-in (I0) and did not rise (Fig. 7, B and D). On the other hand, WT, S1107A, and S1107T mutants showed only very small current rises in the presence of internal 1.7 mm Mg2+, 3 mm spermine, and pH 5.5 (Fig. 7, C and D). This shows that the rising phase of TRPM7 current after break-in is due to the removal of inhibitory cations such as Mg2+ or polyamines and protons. Because S1107E, S1107R, S1107K, and S1107Q (gain-of-function (GOF) mutations) are insensitive to these inhibitory cations, they also do not show a rising phase with 0 internal Mg2+. The S1107C mutant failed to express substantial currents, whereas S1107D behaved as the other GOF mutants (data not shown). These experiments demonstrate that Mg2+ is not unique in its inhibition of TRPM7 and shares this property with other cations, such as polyamines and protons. Nevertheless, GOF mutations did not completely eliminate the Mg2+ sensitivity of TRPM7. At very high free Mg2+ concentrations (tested at 2.9 and 4.9 mm), both the S1107E and S1107K mutant channels were partially inhibited (data not shown).
S1107 gain-of-function mutants are less sensitive to PIP2 depletion by VSP
As a logical next step, we investigated the behavior of mutants with diminished Mg2+, spermine, and pH sensitivity (GOF mutants) by co-expressing CiVSP. We reasoned that if Mg2+, spermine, and protons inhibit TRPM7 by screening PIP2-negative charges, then depleting membrane PIP2 would mimic this behavior. In other words, Mg2+-insensitive mutants may also be VSP-insensitive. Fig. 8A shows whole-cell recordings of WT TRPM7 and two GOF mutants with 0 Mg2+i. As expected, the WT current in VSP-expressing cells increased (because of cytosolic Mg2+ washout) and then decayed over time because of further PIP2 depletion. By contrast, S1107E and S1107R currents lacked a rising phase and decayed significantly less over the same time period (Fig. 8, A and B). This experiment demonstrated that channel sensitivity to Mg2+, polyamines, and protons strongly correlates with their sensitivity to PIP2 depletion, suggesting that they reflect the same process. To explore the sensitivity of TRPM7's local structure to changes at position 1107, a truncated model of TRPM7 was constructed and used to probe the consequences of changes at position 1107 (Fig. 8C). Replacement of serine with various residues examined here caused very modest solvent exposure changes, 1–4%, for residues within 8 Å of position 1107. This result was anticipated because the software we used finds only the structure's closest energy minimum and does not allow for the substantial structural changes necessary to locate a new global energy minimum. The degree of instability/stability introduced into the structure by each residue change was estimated by calculating the change in the force field free energy of the 1107 residue and neighboring residues (within 8 Å) relative to the native structure (Ser-1107). The results are shown in Fig. 8D (see Fig. S2 for the full scale), where the total free energy together with electrostatic and nonbonded components are plotted. The total and nonbonded free energies for the Gln (106,023 kJ and 106,174 kJ, respectively), Lys (2,445 kJ and 2,433 kJ), and Arg (11,455 kJ and 11,699 kJ) substitutions are very large and unfavorable, indicating an extremely large driving force for structural change. Other substitutions (Asp and Glu) are associated with smaller free energy changes but are also unfavorable and of substantial magnitude, indicating a driving force for structural changes in these mutants. Last, the electrostatic interactions are relatively small in magnitude. These results suggest that with Ala, Ser, Cys, or Thr at position 1107, the structure is stable whereas it is not with Asp, Gln, Lys, or Arg at the same position.
Discussion
We have explored the relationship between well-known regulators of TRPM7 channels: membrane phosphoinositides on one hand and cytoplasmic Mg2+, spermine, and pH on the other. We employed expression of VSP to dephosphorylate the endogenous plasma membrane PIP2 and other phosphoinositide substrates, such as PI(3,4,5)P3 (46). Our main findings are as follows. Low Mg2+ and proton concentrations that were not inhibitory in inactive C363S VSP variant–expressing cells (10 μm Mg2+ and pH 8.2) significantly inhibited the native TRPM7 channel current when PIP2 was depleted by WT VSP activity. At higher concentrations, Mg2+ (150 μm) and protons (pH 6.5) were inhibitory in both WT- and C363S VSP–expressing cells but with a faster time course in the former. Native TRPM7 current inhibition by 2-APB was significantly more robust in WT Ciona or zebrafish VSP-expressing cells. Point mutations reducing TRPM7 channel sensitivity to Mg2+ also reduced its sensitivity to spermine and pH. Point mutants insensitive to these cations were also less sensitive to VSP co-expression.
Specifically, several parameters were changed by VSP expression: the extent of current reduction after the initial rise, measured at 5 or 6 min; the time constant of current decay; and the time to reach maximum. During whole-cell recording with low Mg2+, the TRPM7 current develops slowly, reaching maximum amplitude after several minutes of cell dialysis (Fig. 1, A–C). It is thought that this rise time reflects the removal of cytosolic Mg2+ (which likely occurs in seconds) and other downstream events. Whole-cell recordings (without VSP expression) with no Mg-ATP are accompanied by gradual PIP2 depletion (e.g. Refs. 32, 47). In perforated patch recording, which prevents Mg2+ and ATP loss (7, 48), heterologous TRPM7 channel currents were largely time-invariant (Fig. 4A).
Ionized [Mg2+] in mammalian cells is in the 0.5–1 mm range (49–51). In our view, the initial current development or potentiation represents Mg2+ (and proton) removal from PIP2 molecules that are bound to the channels in an intact cell because the average pKa of PIP2 is estimated to be near pH 6.3 (52). We found that the time to maximum was shortened in PIP2-depleted cells (Fig. 2). The difference between C363S and WT VSP-transfected cells was reduced at the high 150 μm Mg2+ concentration, reflecting the fact that this concentration is sufficient to inhibit TRPM7 even in cells not depleted of PIP2. High Mg2+, in effect, occludes PIP2 depletion. We also compared the initial current rise phase in C363S and WT VSP–expressing cells and found a small reduction in the time constant for WT VSP that was not statistically significant. We conclude from these measurements that the effect of PIP2 depletion on the rising phase of the current is primarily due to increasing sensitivity of the channels to Mg2+ and accelerated current decay. We do not rule out a direct effect on the initial rise speed, which could be due to a faster off-rate for Mg2+ when fewer PIP2 molecules are bound to the channel. Conversely, the Mg2+ on-rate, underlying current decline, is enhanced for the same reason; i.e. Mg2+ has to screen fewer PIP2 molecules to close the channels. In other words, the channels become more prone to rundown (31). Alternatively, after binding Mg2+, the PIP2–Mg2+ complex is dissociated from the channel, which might help explain why inhibition is slow, requiring several minutes for completion (Figs. 1 and 2).
Stimulation of Gαq-coupled phospholipase Cβ resulted in inhibition of TRPM7 channels through PIP2 hydrolysis per se because the downstream metabolites diacylglycerol and inositol trisphosphate had no effect (34). Application of water-soluble PIP2 analogs rescued rundown channel activity in that and other reports (7, 13, 34). In our hands, the expression of high levels of CiVSP resulted in significant reductions in both break-in and maximum current amplitudes (Fig. S1), supporting the view that PIP2 is a required cofactor for proper TRPM7 channel function.
We used VSP overexpression to take advantage of testing PIP2 dependence within the physiological range as opposed to applying exogenous water-soluble PIP2 analogs at very high concentrations. In some cases, exogenously applied PIP2 activated ion channels that were later found to be PIP2-insensitive when endogenous phospholipids were depleted by using genetically engineered tools (53, 54).
In WT VSP–expressing cells, the rates of Mg2+-dependent inhibition could be described by single exponential decay functions. We compared the decay time constants at the two Mg2+ concentrations and found that increasing the internal Mg2+ concentration to 150 μm resulted in significantly lower time constants (Fig. 2). We interpret this effect as faster overall on rate of Mg2+ when the number of PIP2 molecules is reduced by VSP. The rate of inhibition by an acidic pH of 6.5 was also substantially higher in PIP2-depleted cells (Fig. 3). Thus, depletion of PIP2 sensitized TRPM7 channels to these inhibitors.
We had to calibrate VSP expression levels to avoid greatly reduced TRPM7 currents (Fig. S1). Surprisingly, even without applying long depolarizing steps, which VSP is believed to require for activation (38), PIP2 levels were apparently lowered when culturing transfected cells for several days. This resulted in great variability of all parameters describing inhibition despite our efforts to keep transfection conditions identical in all cases. Such variability could arise from the differences in resting membrane potentials among HEK cells or differences in VSP expression levels. HEK293 cell resting membrane potentials have been estimated to be in the −50 to −30 mV range (55–58). To investigate whether depolarizing shifts in the resting membrane potential will increase VSP activity, transfected HEK cells were cultured in 25.3 mm KCl–containing RPMI medium for 24 h before recordings were made (Fig. 6F). For HEK cells expressing WT and C363S, the break-in and maximum current amplitudes in high and normal K+ (Fig. 6F) were not statistically significantly different (Student's t test). Our own measurements of HEK cell membrane potential in 4.5 mm [K+]o showed that it varied between −59 and −27 mV (see “Results”). This points to the existence of substantial VSP activity at these negative membrane potentials. Accordingly, it has been demonstrated previously that the CiVSP enzyme is active over a wide range of membrane potentials achievable in patch clamp experiments (42, 44).
We also looked for acute effects of VSP on TRPM7 channel currents by applying a long (2 s) depolarizing step either to +100 mV or to −10 mV and comparing the speed of current decay but saw no noticeable acceleration of current inhibition with +100 mV steps, a sufficient depolarization for VSP activation, used by other investigators for this purpose (e.g. Refs. 35, 53) (data not shown). It appears that, in the case of low-affinity interactions of PIP2 with channels, the basal activity of VSP is sufficient to account for the observed effects on Mg2+ and pH sensitivity. The command voltage ramp protocol applied in our experiments to measure TRPM7 currents briefly reaches +85 mV (see “Experimental procedures”) and may, by itself, be sufficient to activate VSP. This has been proposed for a similar voltage protocol (−120 to +100 mV applied at 1 Hz) used to record TRPM6 (39). Arguing against this scenario is our observation that high-efficiency VSP transfection reduced break-in TRPM7 currents for WT- compared with C363S VSP–expressing cells (Fig. S1).
In addition to PIP2, VSP can hydrolyze PI(3,4,5)P3 while generating PI(4)P in the process (46, 54, 59). Although participation of these phospholipids in TRPM7 channel regulation is not ruled out, most experimental evidence points to PIP2 as the primary anionic phospholipid required for TRPM7 activation (39).
Electrostatic interactions with PIP2 have been linked to increased Mg2+ sensitivity of several ion channels. Hydrolysis of PIP2 resulted in a greater degree and speed of TRPV5 channel inhibition by internal Mg2+ (60). Du et al. (61) showed that the Mg2+ and pH sensitivity of Kir channels depends on the availability of PIP2 and its interaction with the channels. Accordingly, point mutations strengthening Kir2.3 channel–PIP2 interactions reduced channel inhibition by Mg2+ and protons (compare with our Figs. 7 and 8), whereas those weakening Kir2.1-PIP2 interactions increased the Mg2+ and proton sensitivity. The authors proposed that the Mg2+ effect was mediated by stimulation of lipid phosphatases. A dominant-negative point mutation in Kir2.1 linked to Andersen syndrome decreased channels' PIP2 sensitivity, resulting in increased inhibition by Mg2+ (62). PIP2-sensitive KCNE-KCNQ channels are inhibited by intracellular Mg2+ and polyamines, and elevated PIP2 concentrations decreased inhibition by these cations (63). It can be summarized that low-affinity channel-PIP2 interactions are disrupted by physiological levels of Mg2+, protons, and polyamines, whereas high-affinity interactions are less sensitive to these cations (36, 54, 61). In agreement with this view, polyvalent cations with low charge-screening capacity, such as hexamethonium, do not inhibit TRPM7 (7).
We showed previously that inhibition of native TRPM7 channels by 2-APB is not direct but by cytoplasmic acidification induced by this drug (40). In PIP2-depleted cells, same concentration of 2-APB was significantly more potent than in controls (Fig. 5), in agreement with increased pH sensitivity of TRPM7 channels under these conditions (Fig. 3). Inhibition by 2-APB was considerably faster for WT than for C363S, consistent with a faster proton-induced ITRPM7 decline (Fig. 3). It would be instructive to test whether other TRPM7 modulators that depend on internal Mg2+ (64) also demonstrate increased potencies in PIP2-depleted cells.
Several basic residues have been implicated in PIP2 sensitivity of TRPM7 channels. Mutagenesis of basic Lys-1112, Arg-1115, and Lys-1125 (triple mutant) located in the TRP domain (Fig. 7A) to neutral glutamines resulted in nonfunctional channels (39). Because TRPM7 forms a homotetramer (4, 65), these results suggest that mutagenizing these three basic residues in all four subunits completely abolishes channel function. K1112Q TRPM7 (39), however, had low basal activity that could be potentiated by external NH4+ to alkalinize the cytosol and neutralize the inhibitory protons (7, 39). It is not known whether additional PIP2-interacting sites exist in TRPM7 protein and whether every subunit needs to bind PIP2 for the channel to open. For another tetrameric channel, binding to three subunits was sufficient to support channel activity (66). The effect of PIP2 depletion on TRPM7 channels may either represent multiple PIP2 binding sites on each subunit and/or removal of PIP2 from an increasing number of subunits comprising the channel. Further experimentation will be needed to answer this question directly.
Ser-1107 was described as a key residue mediating Mg2+ inhibition of TRPM7 (41) (Fig. 8C): substitution with negatively charged glutamate resulted in channels with greatly reduced Mg2+ sensitivity. We investigated what other amino acid substitutions in this position would reduce Mg2+ sensitivity (gain-of-function mutations). Surprisingly, substituting Ser-1107 with positively charged arginine or lysine resulted in an identical phenotype (Figs. 7 and 8D). Uncharged glutamine also gave rise to channels insensitive to Mg2+ (Figs. 7 and 8D). Substitution with alanine or threonine, on the other hand, resulted in channels that behaved like the WT. We then tested whether these point mutants were sensitive to other positively charged inhibitors such as spermine and protons, finding that the GOF mutants were strikingly less sensitive to both, whereas the S1107A and S1107T mutants were inhibited by all three, like the WT channel (Fig. 7).
We further tested S1107 mutants for their sensitivity to PIP2 depletion by co-expression with VSP. We found that S1107E and S1107R mutants were also significantly less sensitive to VSP-induced PIP2 depletion compared with the WT (Fig. 8, A and B). In combination, these results suggest that Ser-1107 is critical for the sensitivity of TRPM7 to cations, polyamines, and PIP2 interaction and that certain substitutions at this site can disrupt this interaction. Mutations by which PIP2–channel interactions are potentially strengthened (S1107E, S1107R, S1107K, and S1107Q) are also more difficult to disrupt by the screening cations. Indeed, we were able to inhibit GOF mutant currents only by raising [Mg2+] to 2.9 mm and higher (see “Results”). It is notable that the positive regulator of TRPM7 channel activity (PIP2) and the negative regulators (Mg2+, spermine, and protons) share the same site of action, suggesting that Mg2+, polyamines, and pH exert their inhibitory actions through the same mechanism: electrostatic screening (shielding) of the PIP2-negative charge (7). We therefore predict that neomycin and polylysine, polycations that efficiently interact with PIP2, will also be less potent in GOF mutants compared with the WT. We also predict that the S1107D, S1107K, and S1107Q mutants will behave like Glu and Arg, whereas S1107A and S1107T are likely to behave like WT channel in terms of VSP sensitivity. The phenotype of S1107 substitutions does not depend on the charge in that position because arginine, lysine, and glutamate behave similarly. Rather, it depends on the bulk as reflected in the surface area of the substituting amino acid residue (67, 68). Thus, alanine (surface area of 115 Å2) and threonine (140 Å2) mutants are similar to WT serine (115 Å2), whereas larger side chains (Asp, Gln, Glu, Lys, and Arg) with respective surface areas of 150, 180, 190, 200, and 225 Å2 make the channel insensitive to Mg2+ and other cations (Fig. 8D). Acidic glutamate (190 Å2) and uncharged glutamine (180 Å2) behave similarly, having a similar size. The cutoff appears somewhere between 140 and 150 Å2 (residues in red in Fig. 8D) because the threonine mutant behaved as the WT, whereas aspartate was a GOF mutant. Surprisingly, the exposure of residue side chains within the truncated TRPM7 model used here changes very little (1% to 4%) despite variations in the size of the mutant side chains at 1107 (Fig. S2). For some mutations at position 1107 (Gln, Lys, and Arg), energies are extremely large and unfavorable. Others (Asp and Glu) are more modest, but they are also unfavorable and of significant magnitude. This may provide the energetic driving force for a conformational change in the region of residue 1107 that modifies or abolishes PIP2 interactions with the protein. Contributions from electrostatic interactions are not as great as those from nonbonded (steric) interactions and are even stabilizing in the case of Gln and Arg. This suggests that the bulk of the side chains rather than their charge is of greatest consequence. In total, modeling supports functional analyses that indicate that Ala and Cys mutants retain native activity whereas Asp, Glu, Gln, Lys, and Arg do not (Figs. 7 and 8). These findings are unexpected because many publications until now have argued that PIP2 interacts with basic amino acids of the channel protein (e.g. Refs. 39, 54, 69–71). Apparently, the side chain bulk plays an important role in these interactions in the case of TRPM7. We are not aware of other studies implicating amino acid size as a determinant of PIP2 sensitivity of channels. Whether Ser-1107 directly binds PIP2 was not determined. It might, for example, function downstream of PIP2 binding by communicating with the channel gating machinery. It is unlikely to bind Mg2+ or other inhibitory cations, however.
Ser-1107 in TRPM7 or its corresponding Ser-1080 in human TRPM6 have not been identified as phosphorylation sites in intact cells so far, suggesting that they influence TRPM7 channel activity by a mechanism independent of TRPM7/6 kinase activity (72, 73).
In this paper, we demonstrate that PIP2 depletion can mimic the inhibitory effects of internal Mg2+ and pH on TRPM7 channel activity. Our interpretation of VSP data assumes that PI(4,5)P2 phospholipid is its main substrate. Several interesting questions about TRPM7 regulation can be addressed in our future experiments. What is the effect of PIP2 depletion at the single-channel level? Mg2+ inhibition consists of a gradual disappearance of conducting channels and a modest, ∼20% reduction in unitary conductance (31); will VSP-mediated PIP2 depletion mimic both of these effects? The latter effect is particularly interesting because it must involve the ion conduction pathway itself. It is also not known whether pH and polyamine effects on single-channel TRPM7 activity are similar to Mg2+ effects and whether the high-affinity Mg2+ inhibitory site is also PIP2-dependent. The question of the minimum subunit number required to bind PIP2 to activate the channel remains open and will allow a more quantitative description of channel inhibition by polyvalent cations.
Experimental procedures
Cell maintenance and transfection
The HEK293 cell line was maintained in RPMI 1640 medium (Lonza, Walkersville, MD) supplemented with 10% heat-inactivated fetal bovine serum (Fisher Scientific, Fair Lawn, NJ) and penicillin/streptomycin (HyClone) in a cell culture incubator (Forma Scientific, Marietta, OH) at 37 °C and 5% CO2 as described previously (20). Cells were grown in 10-cm polystyrene cell culture dishes (USA Scientific, Ocala, FL) and passaged twice a week. Cells plated in 6-well polystyrene plates (USA Scientific) the day before were transfected either with CiVSP or DrVSP complementary DNA in pIRES2-EGFP bicistronic plasmid vectors provided by Yasushi Okamura (Osaka University, Japan). Inactive C363S (Ciona) and C302S (zebrafish) variants were transfected as negative controls. Transient transfection of plasmid DNA was performed with TransIT-LT1 reagent (Mirus Bio, Madison, WI) according to the manufacturer's recommendations. 2–3 days after transfection, the cells were lifted and transferred to glass-bottom recording chambers. In one series of experiments, the transfection mixture was kept in the wells until the start of recordings (∼48 h) (Fig. S1), whereas in the other series, it was washed away by changing the culture medium after ∼24 h. We found that, after ∼48 h of uninterrupted transfection, the break-in (basal) and maximum current amplitudes were both markedly reduced in WT- compared with CiVSP C363S–transfected cells, resulting in many cells having no detectable endogenous TRPM7 currents (Fig. S1). We therefore conducted our experiments using moderate transfection conditions by removing the transfection reagent after ∼24 h.
The murine TRPM7 coding sequence (18) and its Ser-1107 point mutants in GFP-tagged (in the pEGFP-C1 plasmid vector) or untagged version (in pcDNA3) were transfected at 2.5 μg/well in 6 well-plates, and recordings were made 2–3 days after transfection. For co-transfection, 2.5 μg of TRPM7-pcDNA3 (WT or Ser-1107 point mutants) and 0.6–0.8 μg of WT Ci-VSP plasmid were used per well, and the majority of recordings were made 2 days after transfection. Occasionally, recordings were made 3 days after transfecting with VSP with similar results.
Site-directed mutagenesis
Serine 1107 (41) of murine TRPM7 in pEGFP-C1 and pcDNA3 vectors was mutagenized to alanine, glutamate, glutamine, cysteine, threonine, lysine, or arginine using the QuikChange II XL kit (Promega, Madison, WI). All mutations were verified by DNA sequencing (Retrogen, San Diego, CA).
Patch clamp electrophysiology
Whole-cell patch clamp recordings were performed as described previously (6, 20). Pipettes were manufactured from patch capillary glass (Warner Instruments, Hamden, CT) using a DMZ Universal (Zeitz Instruments, Martinsried, Germany) or P-1000 micropipette puller (Sutter Instrument, Novato, CA) and had resistances of ∼2–4 megaohm. Currents were recorded with an EPC10 patch clamp amplifier and Patchmaster software (HEKA Elektronik, Lambrecht, Germany). On the day of the experiment, cells were lifted off the polystyrene culture plate and transferred to the recording chamber mounted on the mechanical stage of an inverted microscope equipped with epifluorescence (Nikon). Successfully transfected cells were identified by their EGFP fluorescence and selected for patch clamp recording. In several experiments, we also recorded from nonfluorescent cells for comparison to rule out nonspecific transfection effects (Fig. 6F). For recording endogenous TRPM7 currents, the internal (pipette) solution contained 106 mm l-glutamic acid, 8 mm NaCl, 5 mm CsF, 10 mm HEDTA, and 10 mm HEPES acid (pH adjusted to 7.3 with CsOH). For the experiments described in Fig. 3, the pH of this solution was brought to 6.5 or 8.2 on the day of the experiment. For preparing solutions containing 10 μm and 150 μm free Mg2+, glutamic acid and HEDTA concentrations were lowered to 101 mm and 8 mm, respectively. For recordings of overexpressed mTRPM7 and its point mutants (Figs. 7 and 8), the internal solution contained 112 mm glutamic acid, 8 mm NaCl, 5 mm CsF, 12 mm EGTA, 10 mm HEPES acid, and 0.09 mm CaCl2 (pH 7.3 with CsOH). In all experiments (except Fig. 6), the external (bath) solution contained 2 mm CaCl2, 4.5 mm KCl, 140 mm sodium aspartate, 10 mm HEPES-Na+, 3 mm CsCl, and 0.5 mm glucose (pH 7.3). 1.0 m MgCl2 and CaCl2 standard solutions (Sigma-Aldrich, St. Louis, MO) were used for buffer preparation. 20 mm sodium aspartate was replaced with 20 mm sodium propionate in the standard 2 mm Ca2+ buffer to perform the experiments described in Fig. 4.
For Fig. 6, divalent cation–free (DVF) external solution was used, consisting of 140 mm aspartic acid, 6 mm HEDTA, and 10 mm HEPES (pH 7.3 with CsOH) or 140 mm sodium aspartate, 6 mm HEDTA, and 10 mm HEPES (pH 7.3 with NaOH). Deionized water (Nanopure, Barnstead, UK) was used in preparation of recording solutions. Osmolalities were measured with a freezing point depression osmometer (Precision Systems, Dubuque, IA) and adjusted by adding D-mannitol. Free Mg2+ concentrations were calculated with Webmaxc software.
Endogenous HEK cell and heterologous TRPM7 channel currents (20) were evoked by applying 211-ms command voltage ramps ranging from −100 to +85 mV every 2.5 s. In the experiments shown in Figs. 4, 5, 7, and 8, −85 to +85 mV voltage ramps of the same duration and frequency were used, except for a few recordings where 2 s gaps were used (Fig. 7, legend). Current traces were filtered at 2.9 kHz and digitized at 5 kHz. Data acquired with Patchmaster were saved on the hard drive of a personal computer for subsequent analysis. For recording monovalent TRPM7 currents in DVF solutions, voltage ramps from −100 to +20 mV were used (Fig. 6). In some cells, currents continued to rise slowly after 6 min at ∼1.5% per min; these small increases were ignored and 6 min magnitude value taken as the maximum (see Fig. 2).
Occasionally, endogenous ITRPM7 amplitudes recovered again after initial inhibition by 150 μm Mg2+ (data not shown). This rebound phenomenon was only observed in C363S- but not WT VSP–transfected cells. Such cells were excluded from our analysis.
Membrane potentials of untransfected HEK293 cells were measured using the perforated patch technique, essentially as described previously (7). Briefly, an aliquot of amphotericin B (Sigma) prepared in DMSO was dissolved in the internal solution containing 55 mm KCl, 50 mm K2SO4, 7 mm MgCl2, 1 mm CaCl2, and 10 HEPES (pH 7.3) to a final concentration of ∼240 μg/ml. The external solution contained 77 mm sodium aspartate, 62.5 mm NaCl, 2 mm CaCl2, 4.5 mm KCl, 10 mm HEPES–sodium, and 0.5 mm glucose (pH 7.3). Membrane potentials were recorded in current clamp mode continuously for ∼1–6 min (10-kHz sampling rate) with Imembrane = 0 after access resistances dropped to 20 MOhm or lower. For recording TRPM7 currents (Fig. 4A), the perforated patch solution contained Cs+ instead of K+. 7 mm Mg2+ present in this solution was sufficient to inhibit TRPM7 currents when whole-cell break-in occurred spontaneously. All experiments were performed at room temperature (∼25 °C).
Molecular structure presentation
A partial structural model for mouse TRPM7 was developed using homology modeling methods implemented by Phyre2 (74, 75). The α kinase domain, as well as regions of TRPM7 primary structure for which satisfactory structural homologs could not be identified, are not included in our model. To examine the structural consequences of mutations in the truncated TRPM7 model, it was energy-minimized using the GROMOS force field, and the amino acid residue at position 1107 in the sequence was modified to alternate residues using Swiss PDB Viewer utilities. The resultant structures were again energy-minimized. Threading energies at each amino acid residue of these resulting structures were calculated. For each mutant protein, threading energies for residues within 8 Å of position 1107 were used to estimate the energetic consequences of the respective mutation. The solvent-accessible surfaces of each residue in the native and mutated TRPM7 structural models were also determined using Swiss PDB Viewer. Energy calculations were performed using the GROMOS96 43B1 parameter set, without reaction field, as implemented in Swiss PDB Viewer (76). In these calculations, solvent was not explicitly included.
Chemicals and data presentation
l-glutamic acid, HEPES, EGTA, and HEDTA were from Acros Organics (Geel, Belgium). D-mannitol, NaOH, and DMSO were from Fisher Scientific. All other salts and 2-APB were purchased from Sigma-Aldrich. 200 mm stock solution of 2-APB was prepared in DMSO and diluted in the external recording solution on the day of the experiment. Analysis was done by comparing data collected from groups of cells transfected with WT, inactive VSP mutants, and/or mTRPM7 constructs and presented as scatterplots and bar graphs of means ± S.E. Patch clamp data curve fitting and graphing were performed using Origin versions 8, 8.6, and 2016 (OriginLab, Northampton, MA). Numbers of cells in graphs are given in parentheses. Statistical differences were compared using analysis of variance, Student's t test, and Tukey's multiple comparisons test.
Author contributions
T. Z., K. B. W., P. B., and J. A. K. data curation; T. Z., P. B., M. M., and J. A. K. investigation; T. Z., P. B., G. M. A., and J. A. K. methodology; K. B. W., P. B., and J. A. K. formal analysis; G. M. A. software; G. M. A. visualization; M. M. resources; J. A. K. conceptualization; J. A. K. supervision; J. A. K. funding acquisition; J. A. K. validation; J. A. K. writing-original draft; J. A. K. project administration; J. A. K. writing-review and editing.
Supplementary Material
Acknowledgments
We thank Rikki Chokshi for excellent technical assistance; Dr. Madhavi Kadakia for the gift of the HEK293 cell line; Dr. Yasushi Okamura for the CiVSP WT, CiVSP C363S, DrVSP WT, and DrVSP C302S plasmids; Mike Bottomley for help with statistical analysis; and Dr. Dan Halm for comments on an earlier version of the manuscript.
This work was supported by NIAID, National Institutes of Health grants 1R15AI090613 and 1R01AI114804 (to J. A. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
This article contains Figs. S1 and S2.
- TRP
- transient receptor potential
- PI(4,5)P2
- phosphatidyl inositol bisphosphate
- VSP
- voltage-sensing phospholipid phosphatase
- 2-APB
- 2-aminoethyl diphenyl borinate
- HEK
- human embryonic kidney
- I–V
- current–voltage
- GOF
- gain-of-function
- EGFP
- enhanced GFP
- HEDTA
- N-(2-hydroxyethyl)ethylenediaminetriacetic acid
- DVF
- divalent cation–free
- CiVSP
- Ciona intestinalis VSP
- DrVSP
- Danio rerio VSP.
References
- 1. Yamaguchi H., Matsushita M., Nairn A. C., and Kuriyan J. (2001) Crystal structure of the atypical protein kinase domain of a TRP channel with phosphotransferase activity. Mol. Cell 7, 1047–1057 10.1016/S1097-2765(01)00256-8 [DOI] [PubMed] [Google Scholar]
- 2. Middelbeek J., Clark K., Venselaar H., Huynen M. A., and van Leeuwen F. N. (2010) The α-kinase family: an exceptional branch on the protein kinase tree. Cell. Mol. Life Sci. 67, 875–890 10.1007/s00018-009-0215-z [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Runnels L. W. (2011) TRPM6 and TRPM7: a Mul-TRP-PLIK-cation of channel functions. Curr. Pharm. Biotechnol. 12, 42–53 10.2174/138920111793937880 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Cabezas-Bratesco D., Brauchi S., González-Teuber V., Steinberg X., Valencia I., and Colenso C. (2015) The different roles of the channel-kinases TRPM6 and TRPM7. Curr. Med. Chem. 22, 2943–2953 10.2174/0929867322666150716115644 [DOI] [PubMed] [Google Scholar]
- 5. Prakriya M., and Lewis R. S. (2002) Separation and characterization of currents through store-operated CRAC channels and Mg2+-inhibited cation (MIC) channels. J. Gen. Physiol. 119, 487–507 10.1085/jgp.20028551 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Kozak J. A., Kerschbaum H. H., and Cahalan M. D. (2002) Distinct properties of CRAC and MIC channels in RBL cells. J. Gen. Physiol. 120, 221–235 10.1085/jgp.20028601 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Kozak J. A., Matsushita M., Nairn A. C., and Cahalan M. D. (2005) Charge screening by internal pH and polyvalent cations as a mechanism for activation, inhibition, and rundown of TRPM7/MIC channels. J. Gen. Physiol. 126, 499–514 10.1085/jgp.200509324 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Jiang X., Newell E. W., and Schlichter L. C. (2003) Regulation of a TRPM7-like current in rat brain microglia. J. Biol. Chem. 278, 42867–42876 10.1074/jbc.M304487200 [DOI] [PubMed] [Google Scholar]
- 9. Kaitsuka T., Katagiri C., Beesetty P., Nakamura K., Hourani S., Tomizawa K., Kozak J. A., and Matsushita M. (2014) Inactivation of TRPM7 kinase activity does not impair its channel function in mice. Sci. Rep. 4, 5718 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Zierler S., Sumoza-Toledo A., Suzuki S., Dúill F. Ó., Ryazanova L. V., Penner R., Ryazanov A. G., and Fleig A. (2016) TRPM7 kinase activity regulates murine mast cell degranulation. J. Physiol. 594, 2957–2970 10.1113/JP271564 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Yee N. S., Kazi A. A., and Yee R. K. (2014) Cellular and developmental biology of TRPM7 channel-kinase: implicated roles in cancer. Cells 3, 751–777 10.3390/cells3030751 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Kunert-Keil C., Bisping F., Krüger J., and Brinkmeier H. (2006) Tissue-specific expression of TRP channel genes in the mouse and its variation in three different mouse strains. BMC Genomics 7, 159 10.1186/1471-2164-7-159 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Macianskiene R., Gwanyanya A., Vereecke J., and Mubagwa K. (2008) Inhibition of the magnesium-sensitive TRPM7-like channel in cardiac myocytes by nonhydrolysable GTP analogs: involvement of phosphoinositide metabolism. Cell Physiol. Biochem. 22, 109–118 10.1159/000149788 [DOI] [PubMed] [Google Scholar]
- 14. Yogi A., Callera G. E., Tostes R., and Touyz R. M. (2009) Bradykinin regulates calpain and proinflammatory signaling through TRPM7-sensitive pathways in vascular smooth muscle cells. Am. J. Physiol. Regul. Integr. Comp. Physiol. 296, R201–R207 10.1152/ajpregu.90602.2008 [DOI] [PubMed] [Google Scholar]
- 15. Zhang Y. H., Sun H. Y., Chen K. H., Du X. L., Liu B., Cheng L. C., Li X., Jin M. W., and Li G. R. (2012) Evidence for functional expression of TRPM7 channels in human atrial myocytes. Basic Res. Cardiol. 107, 282 10.1007/s00395-012-0282-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Nadler M. J., Hermosura M. C., Inabe K., Perraud A. L., Zhu Q., Stokes A. J., Kurosaki T., Kinet J. P., Penner R., Scharenberg A. M., and Fleig A. (2001) LTRPC7 is a Mg.ATP-regulated divalent cation channel required for cell viability. Nature 411, 590–595 10.1038/35079092 [DOI] [PubMed] [Google Scholar]
- 17. Takezawa R., Schmitz C., Demeuse P., Scharenberg A. M., Penner R., and Fleig A. (2004) Receptor-mediated regulation of the TRPM7 channel through its endogenous protein kinase domain. Proc. Natl. Acad. Sci. U.S.A. 101, 6009–6014 10.1073/pnas.0307565101 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Matsushita M., Kozak J. A., Shimizu Y., McLachlin D. T., Yamaguchi H., Wei F. Y., Tomizawa K., Matsui H., Chait B. T., Cahalan M. D., and Nairn A. C. (2005) Channel function is dissociated from the intrinsic kinase activity and autophosphorylation of TRPM7/ChaK1. J. Biol. Chem. 280, 20793–20803 10.1074/jbc.M413671200 [DOI] [PubMed] [Google Scholar]
- 19. Qin X., Yue Z., Sun B., Yang W., Xie J., Ni E., Feng Y., Mahmood R., Zhang Y., and Yue L. (2013) Sphingosine and FTY720 are potent inhibitors of the transient receptor potential melastatin 7 (TRPM7) channels. Br. J. Pharmacol. 168, 1294–1312 10.1111/bph.12012 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Chokshi R., Matsushita M., and Kozak J. A. (2012) Detailed examination of Mg2+ and pH sensitivity of human TRPM7 channels. Am. J. Physiol. Cell Physiol. 302, C1004–C1011 10.1152/ajpcell.00422.2011 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Inoue H., Murayama T., Tashiro M., Sakurai T., and Konishi M. (2014) Mg(2+)- and ATP-dependent inhibition of transient receptor potential melastatin 7 by oxidative stress. Free Radic. Biol. Med. 72C, 257–266 10.1016/j.freeradbiomed.2014.04.015 [DOI] [PubMed] [Google Scholar]
- 22. Kozak J. A., and Cahalan M. D. (2003) MIC channels are inhibited by internal divalent cations but not ATP. Biophys. J. 84, 922–927 10.1016/S0006-3495(03)74909-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Wang Y. H., Slochower D. R., and Janmey P. A. (2014) Counterion-mediated cluster formation by polyphosphoinositides. Chem. Phys. Lipids 182, 38–51 10.1016/j.chemphyslip.2014.01.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Schmitz C., Perraud A. L., Johnson C. O., Inabe K., Smith M. K., Penner R., Kurosaki T., Fleig A., and Scharenberg A. M. (2003) Regulation of vertebrate cellular Mg2+ homeostasis by TRPM7. Cell 114, 191–200 10.1016/S0092-8674(03)00556-7 [DOI] [PubMed] [Google Scholar]
- 25. Demeuse P., Penner R., and Fleig A. (2006) TRPM7 channel is regulated by magnesium nucleotides via its kinase domain. J. Gen. Physiol. 127, 421–434 10.1085/jgp.200509410 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Zhang Z., Yu H., Huang J., Faouzi M., Schmitz C., Penner R., and Fleig A. (2014) The TRPM6 kinase domain determines the Mg ATP-sensitivity of TRPM7/M6 heteromeric ion channels. J. Biol. Chem. 289, 5217–5227 10.1074/jbc.M113.512285 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Visser D., Middelbeek J., van Leeuwen F. N., and Jalink K. (2014) Function and regulation of the channel-kinase TRPM7 in health and disease. Eur J. Cell Biol. 93, 455–465 10.1016/j.ejcb.2014.07.001 [DOI] [PubMed] [Google Scholar]
- 28. Romagnani A., Vettore V., Rezzonico-Jost T., Hampe S., Rottoli E., Nadolni W., Perotti M., Meier M. A., Hermanns C., Geiger S., Wennemuth G., Recordati C., Matsushita M., Muehlich S., Proietti M., et al. (2017) TRPM7 kinase activity is essential for T cell colonization and alloreactivity in the gut. Nat. Commun. 8, 1917 10.1038/s41467-017-01960-z [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Kerschbaum H. H., Kozak J. A., and Cahalan M. D. (2003) Polyvalent cations as permeant probes of MIC and TRPM7 pores. Biophys. J. 84, 2293–2305 10.1016/S0006-3495(03)75035-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Li M., Du J., Jiang J., Ratzan W., Su L. T., Runnels L. W., and Yue L. (2007) Molecular determinants of Mg2+ and Ca2+ permeability and pH sensitivity in TRPM6 and TRPM7. J. Biol. Chem. 282, 25817–25830 10.1074/jbc.M608972200 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Chokshi R., Matsushita M., and Kozak J. A. (2012) Sensitivity of TRPM7 channels to Mg2+ characterized in cell-free patches of Jurkat T lymphocytes. Am. J. Physiol. Cell Physiol. 302, C1642–C1651 10.1152/ajpcell.00037.2012 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Gwanyanya A., Sipido K. R., Vereecke J., and Mubagwa K. (2006) ATP and PIP2 dependence of the magnesium-inhibited, TRPM7-like cation channel in cardiac myocytes. Am. J. Physiol. Cell Physiol. 291, C627–C635 10.1152/ajpcell.00074.2006 [DOI] [PubMed] [Google Scholar]
- 33. Hilgemann D. W. (1997) Cytoplasmic ATP-dependent regulation of ion transporters and channels: mechanisms and messengers. Annu. Rev. Physiol. 59, 193–220 10.1146/annurev.physiol.59.1.193 [DOI] [PubMed] [Google Scholar]
- 34. Runnels L. W., Yue L., and Clapham D. E. (2002) The TRPM7 channel is inactivated by PIP2 hydrolysis. Nat. Cell Biol. 4, 329–336 10.1038/ncb781 [DOI] [PubMed] [Google Scholar]
- 35. Badheka D., Borbiro I., and Rohacs T. (2015) Transient receptor potential melastatin 3 is a phosphoinositide-dependent ion channel. J. Gen. Physiol. 146, 65–77 10.1085/jgp.201411336 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. Rjasanow A., Leitner M. G., Thallmair V., Halaszovich C. R., and Oliver D. (2015) Ion channel regulation by phosphoinositides analyzed with VSPs-PI(4,5)P2 affinity, phosphoinositide selectivity, and PI(4,5)P2 pool accessibility. Front. Pharmacol. 6, 127 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37. Murata Y., Iwasaki H., Sasaki M., Inaba K., and Okamura Y. (2005) Phosphoinositide phosphatase activity coupled to an intrinsic voltage sensor. Nature 435, 1239–1243 10.1038/nature03650 [DOI] [PubMed] [Google Scholar]
- 38. Murata Y., and Okamura Y. (2007) Depolarization activates the phosphoinositide phosphatase Ci-VSP, as detected in Xenopus oocytes coexpressing sensors of PIP2. J. Physiol. 583, 875–889 10.1113/jphysiol.2007.134775 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39. Xie J., Sun B., Du J., Yang W., Chen H. C., Overton J. D., Runnels L. W., and Yue L. (2011) Phosphatidylinositol 4,5-bisphosphate (PIP2) controls magnesium gatekeeper TRPM6 activity. Sci. Rep. 1, 146 10.1038/srep00146 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40. Chokshi R., Fruasaha P., and Kozak J. A. (2012) 2-Aminoethyl diphenyl borinate (2-APB) inhibits TRPM7 channels through an intracellular acidification mechanism. Channels 6, 362–369 10.4161/chan.21628 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41. Hofmann T., Schäfer S., Linseisen M., Sytik L., Gudermann T., and Chubanov V. (2014) Activation of TRPM7 channels by small molecules under physiological conditions. Pflugers Arch. 466, 2177–2189 10.1007/s00424-014-1488-0 [DOI] [PubMed] [Google Scholar]
- 42. Sakata S., Hossain M. I., and Okamura Y. (2011) Coupling of the phosphatase activity of Ci-VSP to its voltage sensor activity over the entire range of voltage sensitivity. J. Physiol. 589, 2687–2705 10.1113/jphysiol.2011.208165 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43. Thomas P., and Smart T. G. (2005) HEK293 cell line: a vehicle for the expression of recombinant proteins. J. Pharmacol. Toxicol. Methods 51, 187–200 10.1016/j.vascn.2004.08.014 [DOI] [PubMed] [Google Scholar]
- 44. Sakata S., and Okamura Y. (2014) Phosphatase activity of the voltage-sensing phosphatase, VSP, shows graded dependence on the extent of activation of the voltage sensor. J. Physiol. 592, 899–914 10.1113/jphysiol.2013.263640 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45. Hossain M. I., Iwasaki H., Okochi Y., Chahine M., Higashijima S., Nagayama K., and Okamura Y. (2008) Enzyme domain affects the movement of the voltage sensor in ascidian and zebrafish voltage-sensing phosphatases. J. Biol. Chem. 283, 18248–18259 10.1074/jbc.M706184200 [DOI] [PubMed] [Google Scholar]
- 46. Halaszovich C. R., Schreiber D. N., and Oliver D. (2009) Ci-VSP is a depolarization-activated phosphatidylinositol-4,5-bisphosphate and phosphatidylinositol-3,4,5-trisphosphate 5′-phosphatase. J. Biol. Chem. 284, 2106–2113 10.1074/jbc.M803543200 [DOI] [PubMed] [Google Scholar]
- 47. Zakharian E., Cao C., and Rohacs T. (2011) Intracellular ATP supports TRPV6 activity via lipid kinases and the generation of PtdIns(4,5) P2. FASEB J. 25, 3915–3928 10.1096/fj.11-184630 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48. Rae J., Cooper K., Gates P., and Watsky M. (1991) Low access resistance perforated patch recordings using amphotericin B. J. Neurosci. Methods 37, 15–26 10.1016/0165-0270(91)90017-T [DOI] [PubMed] [Google Scholar]
- 49. Grubbs R. D. (2002) Intracellular magnesium and magnesium buffering. Biometals 15, 251–259 10.1023/A:1016026831789 [DOI] [PubMed] [Google Scholar]
- 50. Brandao K., Deason-Towne F., Perraud A. L., and Schmitz C. (2013) The role of Mg2+ in immune cells. Immunol. Res. 55, 261–269 10.1007/s12026-012-8371-x [DOI] [PubMed] [Google Scholar]
- 51. Chaigne-Delalande B., and Lenardo M. J. (2014) Divalent cation signaling in immune cells. Trends Immunol. 35, 332–344 10.1016/j.it.2014.05.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52. Srivastava J., Barber D. L., and Jacobson M. P. (2007) Intracellular pH sensors: design principles and functional significance. Physiology 22, 30–39 10.1152/physiol.00035.2006 [DOI] [PubMed] [Google Scholar]
- 53. Lindner M., Leitner M. G., Halaszovich C. R., Hammond G. R., and Oliver D. (2011) Probing the regulation of TASK potassium channels by PI4,5P2 with switchable phosphoinositide phosphatases. J. Physiol. 589, 3149–3162 10.1113/jphysiol.2011.208983 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54. Hille B., Dickson E. J., Kruse M., Vivas O., and Suh B. C. (2015) Phosphoinositides regulate ion channels. Biochim. Biophys. Acta 1851, 844–856 10.1016/j.bbalip.2014.09.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55. Fliegert R., Glassmeier G., Schmid F., Cornils K., Genisyuerek S., Harneit A., Schwarz J. R., and Guse A. H. (2007) Modulation of Ca2+ entry and plasma membrane potential by human TRPM4b. FEBS J. 274, 704–713 10.1111/j.1742-4658.2006.05614.x [DOI] [PubMed] [Google Scholar]
- 56. Saleem F., Rowe I. C., and Shipston M. J. (2009) Characterization of BK channel splice variants using membrane potential dyes. Br. J. Pharmacol. 156, 143–152 10.1111/j.1476-5381.2008.00011.x [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57. Hsu K., Han J., Shinlapawittayatorn K., Deschenes I., and Marbán E. (2010) Membrane potential depolarization as a triggering mechanism for Vpu-mediated HIV-1 release. Biophys. J. 99, 1718–1725 10.1016/j.bpj.2010.07.027 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58. Babai N., Kanevsky N., Dascal N., Rozanski G. J., Singh D. P., Fatma N., and Thoreson W. B. (2010) Anion-sensitive regions of L-type CaV1.2 calcium channels expressed in HEK293 cells. PLoS ONE 5, e8602 10.1371/journal.pone.0008602 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59. Iwasaki H., Murata Y., Kim Y., Hossain M. I., Worby C. A., Dixon J. E., McCormack T., Sasaki T., and Okamura Y. (2008) A voltage-sensing phosphatase, Ci-VSP, which shares sequence identity with PTEN, dephosphorylates phosphatidylinositol 4,5-bisphosphate. Proc. Natl. Acad. Sci. U.S.A. 105, 7970–7975 10.1073/pnas.0803936105 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60. Lee J., Cha S. K., Sun T. J., and Huang C. L. (2005) PIP2 activates TRPV5 and releases its inhibition by intracellular Mg2+. J. Gen. Physiol. 126, 439–451 10.1085/jgp.200509314 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61. Du X., Zhang H., Lopes C., Mirshahi T., Rohacs T., and Logothetis D. E. (2004) Characteristic interactions with PIP2 determine regulation of Kir channels by diverse modulators. J. Biol. Chem. 279, 37271–37281 10.1074/jbc.M403413200 [DOI] [PubMed] [Google Scholar]
- 62. Ballester L. Y., Vanoye C. G., and George A. L. Jr. (2007) Exaggerated Mg2+ inhibition of Kir2.1 as a consequence of reduced PIP2 sensitivity in Andersen syndrome. Channels 1, 209–217 10.4161/chan.4770 [DOI] [PubMed] [Google Scholar]
- 63. Suh B. C., and Hille B. (2007) Electrostatic interaction of internal Mg2+ with membrane PIP2 seen with KCNQ K+ channels. J. Gen. Physiol. 130, 241–256 10.1085/jgp.200709821 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64. Chubanov V., Schäfer S., Ferioli S., and Gudermann T. (2014) Natural and synthetic modulators of the TRPM7 channel. Cells 3, 1089–1101 10.3390/cells3041089 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65. Zheng J. (2013) Molecular mechanism of TRP channels. Compr. Physiol. 3, 221–242 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66. Marius P., Zagnoni M., Sandison M. E., East J. M., Morgan H., and Lee A. G. (2008) Binding of anionic lipids to at least three nonannular sites on the potassium channel KcsA is required for channel opening. Biophys. J. 94, 1689–1698 10.1529/biophysj.107.117507 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67. Zamyatnin A. A. (1972) Protein volume in solution. Prog. Biophys. Mol. Biol. 24, 107–123 10.1016/0079-6107(72)90005-3 [DOI] [PubMed] [Google Scholar]
- 68. Chothia C. (1976) The nature of the accessible and buried surfaces in proteins. J. Mol. Biol. 105, 1–12 10.1016/0022-2836(76)90191-1 [DOI] [PubMed] [Google Scholar]
- 69. Shyng S. L., Cukras C. A., Harwood J., and Nichols C. G. (2000) Structural determinants of PIP2 regulation of inward rectifier K(ATP) channels. J. Gen. Physiol. 116, 599–608 10.1085/jgp.116.5.599 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70. Lopes C. M., Zhang H., Rohacs T., Jin T., Yang J., and Logothetis D. E. (2002) Alterations in conserved Kir channel-PIP2 interactions underlie channelopathies. Neuron 34, 933–944 10.1016/S0896-6273(02)00725-0 [DOI] [PubMed] [Google Scholar]
- 71. Nilius B., Mahieu F., Karashima Y., and Voets T. (2007) Regulation of TRP channels: a voltage-lipid connection. Biochem. Soc. Trans. 35, 105–108 10.1042/BST0350105 [DOI] [PubMed] [Google Scholar]
- 72. Cai N., Bai Z., Nanda V., and Runnels L. W. (2017) Mass spectrometric analysis of TRPM6 and TRPM7 phosphorylation reveals regulatory mechanisms of the channel-kinases. Sci. Rep. 7, 42739 10.1038/srep42739 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73. Kim T. Y., Shin S. K., Song M. Y., Lee J. E., and Park K. S. (2012) Identification of the phosphorylation sites on intact TRPM7 channels from mammalian cells. Biochem. Biophys. Res. Commun. 417, 1030–1034 10.1016/j.bbrc.2011.12.085 [DOI] [PubMed] [Google Scholar]
- 74. Kelley L. A., Mezulis S., Yates C. M., Wass M. N., and Sternberg M. J. (2015) The Phyre2 web portal for protein modeling, prediction and analysis. Nat. Protoc. 10, 845–858 10.1038/nprot.2015.053 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75. Mezulis S., Sternberg M. J. E., and Kelley L. A. (2016) PhyreStorm: a web server for fast structural searches against the PDB. J. Mol. Biol. 428, 702–708 10.1016/j.jmb.2015.10.017 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76. Guex N., and Peitsch M. C. (1997) SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 18, 2714–2723 10.1002/elps.1150181505 [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.